Loratadine Market Size, Share & Trends Analysis Report By Product Type (Medicine Standard Grade, USP Standard Grade, EP Standard Grade), By Dosage Form (Syrup, Tablets, Capsules), By End-User (Online Pharmacy, Hospital Pharmacy, Retail Pharmacy) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Mitiksha Koul | Format: | Report Code: SRPH56103DR | Pages: 156

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Regulatory Framework
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  7. ESG Trends

  8. Global Loratadine Market Size Analysis
    1. Global Loratadine Market Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Medicine Standard Grade
        1. By Value
      3. USP Standard Grade
        1. By Value
      4. EP Standard Grade
        1. By Value
    3. By Dosage Form
      1. Introduction
        1. Dosage Form By Value
      2. Syrup
        1. By Value
      3. Tablets
        1. By Value
      4. Capsules
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2.  Online Pharmacy
        1. By Value
      3.  Hospital Pharmacy
        1. By Value
      4.  Retail Pharmacy
        1. By Value
  9. North America Market Analysis
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Medicine Standard Grade
        1. By Value
      3. USP Standard Grade
        1. By Value
      4. EP Standard Grade
        1. By Value
    3. By Dosage Form
      1. Introduction
        1. Dosage Form By Value
      2. Syrup
        1. By Value
      3. Tablets
        1. By Value
      4. Capsules
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2.  Online Pharmacy
        1. By Value
      3.  Hospital Pharmacy
        1. By Value
      4.  Retail Pharmacy
        1. By Value
    5. U.S.
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Medicine Standard Grade
          1. By Value
        3. USP Standard Grade
          1. By Value
        4. EP Standard Grade
          1. By Value
      2. By Dosage Form
        1. Introduction
          1. Dosage Form By Value
        2. Syrup
          1. By Value
        3. Tablets
          1. By Value
        4. Capsules
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2.  Online Pharmacy
          1. By Value
        3.  Hospital Pharmacy
          1. By Value
        4.  Retail Pharmacy
          1. By Value
    6. Canada
  10. Europe Market Analysis
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Medicine Standard Grade
        1. By Value
      3. USP Standard Grade
        1. By Value
      4. EP Standard Grade
        1. By Value
    3. By Dosage Form
      1. Introduction
        1. Dosage Form By Value
      2. Syrup
        1. By Value
      3. Tablets
        1. By Value
      4. Capsules
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2.  Online Pharmacy
        1. By Value
      3.  Hospital Pharmacy
        1. By Value
      4.  Retail Pharmacy
        1. By Value
    5. U.K.
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Medicine Standard Grade
          1. By Value
        3. USP Standard Grade
          1. By Value
        4. EP Standard Grade
          1. By Value
      2. By Dosage Form
        1. Introduction
          1. Dosage Form By Value
        2. Syrup
          1. By Value
        3. Tablets
          1. By Value
        4. Capsules
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2.  Online Pharmacy
          1. By Value
        3.  Hospital Pharmacy
          1. By Value
        4.  Retail Pharmacy
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
  11. APAC Market Analysis
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Medicine Standard Grade
        1. By Value
      3. USP Standard Grade
        1. By Value
      4. EP Standard Grade
        1. By Value
    3. By Dosage Form
      1. Introduction
        1. Dosage Form By Value
      2. Syrup
        1. By Value
      3. Tablets
        1. By Value
      4. Capsules
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2.  Online Pharmacy
        1. By Value
      3.  Hospital Pharmacy
        1. By Value
      4.  Retail Pharmacy
        1. By Value
    5. China
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Medicine Standard Grade
          1. By Value
        3. USP Standard Grade
          1. By Value
        4. EP Standard Grade
          1. By Value
      2. By Dosage Form
        1. Introduction
          1. Dosage Form By Value
        2. Syrup
          1. By Value
        3. Tablets
          1. By Value
        4. Capsules
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2.  Online Pharmacy
          1. By Value
        3.  Hospital Pharmacy
          1. By Value
        4.  Retail Pharmacy
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Singapore
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
  12. Middle East and Africa Market Analysis
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Medicine Standard Grade
        1. By Value
      3. USP Standard Grade
        1. By Value
      4. EP Standard Grade
        1. By Value
    3. By Dosage Form
      1. Introduction
        1. Dosage Form By Value
      2. Syrup
        1. By Value
      3. Tablets
        1. By Value
      4. Capsules
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2.  Online Pharmacy
        1. By Value
      3.  Hospital Pharmacy
        1. By Value
      4.  Retail Pharmacy
        1. By Value
    5. UAE
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Medicine Standard Grade
          1. By Value
        3. USP Standard Grade
          1. By Value
        4. EP Standard Grade
          1. By Value
      2. By Dosage Form
        1. Introduction
          1. Dosage Form By Value
        2. Syrup
          1. By Value
        3. Tablets
          1. By Value
        4. Capsules
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2.  Online Pharmacy
          1. By Value
        3.  Hospital Pharmacy
          1. By Value
        4.  Retail Pharmacy
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
  13. LATAM Market Analysis
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Medicine Standard Grade
        1. By Value
      3. USP Standard Grade
        1. By Value
      4. EP Standard Grade
        1. By Value
    3. By Dosage Form
      1. Introduction
        1. Dosage Form By Value
      2. Syrup
        1. By Value
      3. Tablets
        1. By Value
      4. Capsules
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2.  Online Pharmacy
        1. By Value
      3.  Hospital Pharmacy
        1. By Value
      4.  Retail Pharmacy
        1. By Value
    5. Brazil
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Medicine Standard Grade
          1. By Value
        3. USP Standard Grade
          1. By Value
        4. EP Standard Grade
          1. By Value
      2. By Dosage Form
        1. Introduction
          1. Dosage Form By Value
        2. Syrup
          1. By Value
        3. Tablets
          1. By Value
        4. Capsules
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2.  Online Pharmacy
          1. By Value
        3.  Hospital Pharmacy
          1. By Value
        4.  Retail Pharmacy
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
  14. Competitive Landscape
    1. Loratadine Market Share By Players
    2. M&A Agreements & Collaboration Analysis
  15. Market Players Assessment
    1. EUROIMMUN Medizinische Labordiagnostika AG
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. AESKU.GROUP GmbH
    3. Danaher
    4. Stallergenes Greer
    5. Siemens Healthcare GmbH
    6. HYCOR Biomedical
    7. Alcon
    8. AbbVie Inc.
    9. Sanofi
    10. Teva Pharmaceutical Industries Ltd.
    11. GSK plc
    12. Merck & Co., Inc.
    13. R-Biopharm AG
    14. DASIT Group SPA
    15. Thermo Fisher Scientific, Inc
  16. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  17. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  18. Disclaimer

Download Free Sample

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on: